HypospadiasNCT07006922
Can a Platelet-Rich Plasma Covering Layer Reduce Urethrocutaneous Fistula Rate After Distal Penile Hypospadias Repair Using the STAR Technique: A Randomized Controlled Trial
A study testing hypospadias repair using the STAR technique with PRP as protective layer and hypospadias repair using the STAR technique in people with Hypospadias and Pediatric Urology, run by Cairo University at 1 site in Egypt.
Trial summary
Methods We conducted a prospective randomized controlled study at the Pediatric Urology Department of Cairo University Specialized Pediatric Hospital between July 2024 and January 2025 . The study included boys undergoing primary repair of distal penile hypospadias. Read more about this study
- Who is it for?
- Ages 6 months to 14 years, men only
- Conditions the study is for
- Hypospadias, Pediatric Urology
- What is being tested?
- hypospadias repair using the STAR technique with PRP as protective layer and hypospadias repair using the STAR technique
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 44 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Jul 2024to 1 Jan 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 months to 14 years
- Men only
- No healthy volunteers
- Child
Who may be able to join
- Pediatric patients with distal penile hypospadias, primary or fresh cases will be selected and circumcised or uncircumcised are included
Who cannot join
- Pediatric patients with other types of hypospadias, distal penile hypospadias who has history of previous surgical trail
Trial locations and contacts
1 site in 1 country.
About this study
Methods We conducted a prospective randomized controlled study at the Pediatric Urology Department of Cairo University Specialized Pediatric Hospital between July 2024 and January 2025 . The study included boys undergoing primary repair of distal penile hypospadias. Ethical approval was obtained from the institution's review board, and informed consent was secured from the parents or legal guardians of all participants.
The study included distal penile hypospadias (glandular, coronal, or subcoronal meatus). Exclusion criteria were: proximal or mid-penile hypospadias, any history of prior hypospadias repair, bleeding or coagulation disorders and other significant genitourinary anomalies.
Read more
The participants were randomly allocated into two equal groups using simple randomization (sealed envelope method). Group A (PRP group) underwent repair with the STAR technique plus an intermediate PRP covering layer. Group B (Control group) underwent repair using the same technique but without PRP. All surgeries were performed by the same pediatric urologist, an experienced surgeon in hypospadias repair, to eliminate inter-surgeon variability.
All patients were operated on under general anesthesia with caudal block analgesia. A standard STAR hypospadias repair was carried out in each case as described by Seleim (10). In brief, the STAR technique involves anatomical reassembly of penile tissues guided by the topography of the glans and corpus spongiosum (the exclusive zipping-up of the unfolded spongiosal plate). A fine-tipped tenotomy scissor used for dissection, starting at the apex of the hypoplastic "V" and extending into the ventral edges of the hooded prepuce on each side, following the demarcation lines. Then, a midline cutting back of the ventral hypoplastic urothelial sheet from the hypospadias meatus to the point of spongiosal bifurcation was made . Excision of the hypoplastic skin ridge all the way from the point of bifurcation till each ipsilateral ventral endpoint of the glanular meatal marks to maximize the epithelialized endoluminal surface of the newly zipped-up spongiosal plate. An interrupted single -layedred spongioplasty ( zipper closure) using 6/0 Vicryl Absorbable sutures (13mm needle, Ethicon Inc, Somerville, New Jersey) is applied over a naeleton catheter . Lastly, the glansplasty is done using 3 slanting sutures. In Group A, before skin closure, a PRP layer was applied over the neourethra, whereas in Group B the repair proceeded directly to skin closure without PRP.
PRP Preparation and Application In Group A patients, approximately 5-10 mL of the child's blood was drawn from a peripheral vein at the start of the operation. The blood was collected into a sterile tube without anticoagulant additives and immediately centrifuged at ~3000 rpm for 20 minutes. This process separated the blood into three components: an upper platelet-poor plasma, a middle platelet-rich plasma, and a bottom red blood cell layer. The platelet-rich plasma fraction was then isolated. After the neourethra was constructed and prior to skin closure, the PRP was applied directly as a liquid/gel onto the repair site covering the neourethra. In a few minutes, PRP forms a clot-like gel layer. No additional dartos or fascia flaps were used in either group, in keeping with the STAR technique's usual practice.
Postoperative Care and Follow-up All patients had a compressive dressing applied, which was removed on the third postoperative day. A urethral stent catheter was left in place to divert urine; this was kept for 7 days postoperatively. Broad-spectrum prophylactic antibiotics were given while the catheter was in situ. Parents were instructed on catheter care and advised to ensure the child avoided straddling activities.
After catheter removal, the urinary stream was observed to ensure it was not deviated or weak. Patients were followed up weekly for at least 4 weeks after surgery, and then monthly up to 3 months. At each follow-up visit, the penis was examined for any complications including urethrocutaneous fistula, meatal stenosis, wound infection, glans dehiscence, and persistent edema or flap necrosis.
Cosmetic and functional outcomes were evaluated at the 1-month visit and again at 3 months using the HOSE score, which assigns points for meatal location, meatal shape, urinary stream, erection straightness, and overall appearance. A higher HOSE score (maximum 16) indicates a more favorable outcome.
Outcome Measures The primary outcome measure was the occurrence of urethrocutaneous fistula within the follow-up period. Key secondary outcomes included incidence of other complications (edema, infection, meatal stenosis, glans dehiscence), the operative time (skin-to-skin surgical duration in minutes), and the cosmetic outcome (HOSE score and meatal configuration).
Statistical Analysis Data were analyzed using the statistics software, SPSS software (IBM SPSS, v25). Continuous variables like age and operative time were not normall
- Conditions
- Hypospadias, Pediatric Urology
- Being tested
- hypospadias repair using the STAR technique with PRP as protective layer, hypospadias repair using the STAR technique
- Keywords
- Platelet-Rich Plasma, Hypospadias Repair, Urethrocutaneous Fistula, Pediatric Urology., STAR Technique
- Medical subject headings
- Hypospadias
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
hypospadias repair using the STAR technique with PRP as protective layerProcedure or surgery
the STAR technique involves anatomical reassembly of penile tissues guided by the topography of the glans and corpus spongiosum (the exclusive zipping-up of the unfolded spongiosal plate). A fine-tipped tenotomy scissor used for dissection, starting at the apex of the hypoplastic "V" and extending into the ventral edges of the hooded prepuce on each side, following the demarcation lines. Then, a midline cutting back of the ventral hypoplastic urothelial sheet from the hypospadias meatus to the point of spongiosal bifurcation was made . Excision of the hypoplastic skin ridge all the way from the point of bifurcation till each ipsilateral ventral endpoint of the glanular meatal marks to maximize the epithelialized endoluminal surface of the newly zipped-up spongiosal plate. An interrupted single -layedred spongioplasty ( zipper closure) using 6/0 Vicryl Absorbable sutures (13mm needle, Ethicon Inc, Somerville, New Jersey) is applied over a naeleton catheter . Lastly, the glansplasty is d
hypospadias repair using the STAR techniqueProcedure or surgery
the STAR technique involves anatomical reassembly of penile tissues guided by the topography of the glans and corpus spongiosum (the exclusive zipping-up of the unfolded spongiosal plate). A fine-tipped tenotomy scissor used for dissection, starting at the apex of the hypoplastic "V" and extending into the ventral edges of the hooded prepuce on each side, following the demarcation lines. Then, a midline cutting back of the ventral hypoplastic urothelial sheet from the hypospadias meatus to the point of spongiosal bifurcation was made . Excision of the hypoplastic skin ridge all the way from the point of bifurcation till each ipsilateral ventral endpoint of the glanular meatal marks to maximize the epithelialized endoluminal surface of the newly zipped-up spongiosal plate. An interrupted single -layedred spongioplasty ( zipper closure) using 6/0 Vicryl Absorbable sutures (13mm needle, Ethicon Inc, Somerville, New Jersey) is applied over a naeleton catheter . Lastly, the glansplasty is d
| Study group | Role | What they receive |
|---|---|---|
| STAR+ PRP | Experimental | underwent repair using the STAR technique with an additional PRP layer over the neourethra Receives: Procedure: hypospadias repair using the STAR technique with PRP as protective layer |
| STAR only | Experimental | received the STAR repair without PRP Receives: Procedure: hypospadias repair using the STAR technique |
What is being measured
The primary outcome is the main question the study is designed to answer.
urethrocutaneous fistula
Measured: 4 weeks
Secondary outcomes (1)
postoperative complications (edema, infection, meatal stenosis), operative time, and cosmetic outcome using the Hypospadias Objective Scoring Evaluation (HOSE).
Measured: 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Jun 2025
- Study start1 Jul 2024
- Primary completion1 Jan 2025
- Study completion1 Jan 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HypospadiasStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 44 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mohamed Abdelghany, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07006922
- Sponsor's protocol ID
- MS*225-2024
- Status last verified
- Jul 2024
- First submitted
- 28 May 2025
- Last updated
- 5 Jun 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Can a Platelet-Rich Plasma Covering Layer Reduce Urethrocutaneous Fistula Rate After Distal Penile Hypospadias Repair Using the STAR Technique: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07006922
- Acronym / sponsor ID
- MS*225-2024
- Conditions
- Hypospadias, Pediatric Urology
- Keywords
- Platelet-Rich Plasma, Hypospadias Repair, Urethrocutaneous Fistula, Pediatric Urology., STAR Technique
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 44 participants (actual)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 1 Jul 2024 (actual)
- Primary completion
- 1 Jan 2025 (actual)
- Study completion
- 1 Jan 2025 (actual)
- First posted
- 5 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Methods We conducted a prospective randomized controlled study at the Pediatric Urology Department of Cairo University Specialized Pediatric Hospital between July 2024 and January 2025 . The study included boys undergoing primary repair of distal penile hypospadias. Ethical approval was obtained from the institution's review board, and informed consent was secured from the parents or legal guardians of all participants.
The study included distal penile hypospadias (glandular, coronal, or subcoronal meatus). Exclusion criteria were: proximal or mid-penile hypospadias, any history of prior hypospadias repair, bleeding or coagulation disorders and other significant genitourinary anomalies.
The participants were randomly allocated into two equal groups using simple randomization (sealed envelope method). Group A (PRP group) underwent repair with the STAR technique plus an intermediate PRP covering layer. Group B (Control group) underwent repair using the same technique but without PRP. All surgeries were performed by the same pediatric urologist, an experienced surgeon in hypospadias repair, to eliminate inter-surgeon variability.
All patients were operated on under general anesthesia with caudal block analgesia. A standard STAR hypospadias repair was carried out in each case as described by Seleim (10). In brief, the STAR technique involves anatomical reassembly of penile tissues guided by the topography of the glans and corpus spongiosum (the exclusive zipping-up of the unfolded spongiosal plate). A fine-tipped tenotomy scissor used for dissection, starting at the apex of the hypoplastic "V" and extending into the ventral edges of the hooded prepuce on each side, following the demarcation lines. Then, a midline cutting back of the ventral hypoplastic urothelial sheet from the hypospadias meatus to the point of spongiosal bifurcation was made . Excision of the hypoplastic skin ridge all the way from the point of bifurcation till each ipsilateral ventral endpoint of the glanular meatal marks to maximize the epithelialized endoluminal surface of the newly zipped-up spongiosal plate. An interrupted single -layedred spongioplasty ( zipper closure) using 6/0 Vicryl Absorbable sutures (13mm needle, Ethicon Inc, Somerville, New Jersey) is applied over a naeleton catheter . Lastly, the glansplasty is done using 3 slanting sutures. In Group A, before skin closure, a PRP layer was applied over the neourethra, whereas in Group B the repair proceeded directly to skin closure without PRP.
PRP Preparation and Application In Group A patients, approximately 5-10 mL of the child's blood was drawn from a peripheral vein at the start of the operation. The blood was collected into a sterile tube without anticoagulant additives and immediately centrifuged at ~3000 rpm for 20 minutes. This process separated the blood into three components: an upper platelet-poor plasma, a middle platelet-rich plasma, and a bottom red blood cell layer. The platelet-rich plasma fraction was then isolated. After the neourethra was constructed and prior to skin closure, the PRP was applied directly as a liquid/gel onto the repair site covering the neourethra. In a few minutes, PRP forms a clot-like gel layer. No additional dartos or fascia flaps were used in either group, in keeping with the STAR technique's usual practice.
Postoperative Care and Follow-up All patients had a compressive dressing applied, which was removed on the third postoperative day. A urethral stent catheter was left in place to divert urine; this was kept for 7 days postoperatively. Broad-spectrum prophylactic antibiotics were given while the catheter was in situ. Parents were instructed on catheter care and advised to ensure the child avoided straddling activities.
After catheter removal, the urinary stream was observed to ensure it was not deviated or weak. Patients were followed up weekly for at least 4 weeks after surgery, and then monthly up to 3 months. At each follow-up visit, the penis was examined for any complications including urethrocutaneous fistula, meatal stenosis, wound infection, glans dehiscence, and persistent edema or flap necrosis.
Cosmetic and functional outcomes were evaluated at the 1-month visit and again at 3 months using the HOSE score, which assigns points for meatal location, meatal shape, urinary stream, erection straightness, and overall appearance. A higher HOSE score (maximum 16) indicates a more favorable outcome.
Outcome Measures The primary outcome measure was the occurrence of urethrocutaneous fistula within the follow-up period. Key secondary outcomes included incidence of other complications (edema, infection, meatal stenosis, glans dehiscence), the operative time (skin-to-skin surgical duration in minutes), and the cosmetic outcome (HOSE score and meatal configuration).
Statistical Analysis Data were analyzed using the statistics software, SPSS software (IBM SPSS, v25). Continuous variables like age and operative time were not normall
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| STAR+ PRP | Experimental | Procedure: hypospadias repair using the STAR technique with PRP as protective layerunderwent repair using the STAR technique with an additional PRP layer over the neourethra |
| STAR only | Experimental | Procedure: hypospadias repair using the STAR techniquereceived the STAR repair without PRP |
Who may qualify
- Ages
- 6 months to 14 years
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (1 listed)
- Pediatric patients with distal penile hypospadias, primary or fresh cases will be selected and circumcised or uncircumcised are included
Key exclusion criteria (1 listed)
- Pediatric patients with other types of hypospadias, distal penile hypospadias who has history of previous surgical trail
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| hypospadias repair using the STAR technique with PRP as protective layerthe STAR technique involves anatomical reassembly of penile tissues guided by the topography of the glans and corpus spongiosum (the exclusive zipping-up of the unfolded spongiosal plate). A fine-tipped tenotomy scissor used for dissection, starting at the apex of the hypoplastic "V" and extending into the ventral edges of the hooded prepuce on each side, following the demarcation lines. Then, a midline cutting back of the ventral hypoplastic urothelial sheet from the hypospadias meatus to the point of spongiosal bifurcation was made . Excision of the hypoplastic skin ridge all the way from the point of bifurcation till each ipsilateral ventral endpoint of the glanular meatal marks to maximize the epithelialized endoluminal surface of the newly zipped-up spongiosal plate. An interrupted single -layedred spongioplasty ( zipper closure) using 6/0 Vicryl Absorbable sutures (13mm needle, Ethicon Inc, Somerville, New Jersey) is applied over a naeleton catheter . Lastly, the glansplasty is d | Procedure or surgery | STAR+ PRP |
| hypospadias repair using the STAR techniquethe STAR technique involves anatomical reassembly of penile tissues guided by the topography of the glans and corpus spongiosum (the exclusive zipping-up of the unfolded spongiosal plate). A fine-tipped tenotomy scissor used for dissection, starting at the apex of the hypoplastic "V" and extending into the ventral edges of the hooded prepuce on each side, following the demarcation lines. Then, a midline cutting back of the ventral hypoplastic urothelial sheet from the hypospadias meatus to the point of spongiosal bifurcation was made . Excision of the hypoplastic skin ridge all the way from the point of bifurcation till each ipsilateral ventral endpoint of the glanular meatal marks to maximize the epithelialized endoluminal surface of the newly zipped-up spongiosal plate. An interrupted single -layedred spongioplasty ( zipper closure) using 6/0 Vicryl Absorbable sutures (13mm needle, Ethicon Inc, Somerville, New Jersey) is applied over a naeleton catheter . Lastly, the glansplasty is d | Procedure or surgery | STAR only |
Primary outcome
urethrocutaneous fistula
Time frame: 4 weeks
1 secondary outcome
postoperative complications (edema, infection, meatal stenosis), operative time, and cosmetic outcome using the Hypospadias Objective Scoring Evaluation (HOSE).
Time frame: 4 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Jun 2025.
Related trials for Hypospadias
Not yet recruitingPhase 4
Effect of Oxybutynin on Opioid Use After Urologic Surgery in Children
Ureteropelvic Junction Obstruction, Hypospadias
Recruiting
Worldwide Yearly Screening for Hypospadias
Hypospadias
Not yet recruitingPhase 4
Emerging Indications for Hyperbaric Oxygen Treatment
Post-COVID-19 Condition, Ulcerative Colitis
Active, not recruiting
Evaluating the Efficacy and Safety of Tranexamic Acid in Reducing Perioperative Bleeding During Recurrent Hypospadias Repair.
Perioperative Bleeding During Recurrent Hypospadias Repair
Not yet recruiting
Efficacy of PRF in Hypospadias Repair
Hypospadias
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing hypospadias repair using the STAR technique with PRP as protective layer and hypospadias repair using the STAR technique in people with Hypospadias and Pediatric Urology, run by Cairo University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
urethrocutaneous fistula (time frame: 4 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jun 2025.